Kainos Group plc Block Admission (0963G)

TIDMKNOS

RNS Number : 0963G

Kainos Group plc

01 November 2018

1 November 2018

Kainos Group plc

("Kainos" or the "Company")

Block Admission

Kainos announces that an application has been made to the Financial Conduct Authority and the London Stock Exchange for a total of 1,000,000 ordinary shares of 0.5 pence each (the "Shares") to be admitted to the Official List.

The Shares are expected to be admitted to the Official List and to trading on the London Stock Exchange on 6 November 2018.

These Shares are being reserved under a block listing and will be issued as a result of the award of shares pursuant to the Company's long term incentive plans, and SAYE plans, as follows:

 
 2015 SAYE         250,000 
 2015 PSP          220,000 
                  ---------- 
 2015 CSOP         430,000 
                  ---------- 
 POLAND 2015       60,000 
                  ---------- 
 2015 RSS (ROI)    40,000 
                  ---------- 
 TOTAL             1,000,000 
                  ---------- 
 

When issued, these Shares will rank pari passu with the existing ordinary shares.

Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47

Ends

For further information, please contact:

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Investec Bank plc [phone]

Patrick Robb / Sebastian Lawrence

Canaccord Genuity [phone]

Simon Bridges / Emma Gabriel

FTI Consulting LLP [phone]

Matt Dixon / Harry Staight

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers.

Kainos has over 1,300 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

ALSUASVRWBAARAA

(END) Dow Jones Newswires

November 01, 2018 11:53 ET (15:53 GMT)